Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Advancing Healthcare Outcomes for Sickle Cell Disease in Nigeria Using Mobile Health Tools

Arwa Fraiwan, PhD, Muhammad Noman Hasan, MS, Ran An, PhD, Amy J. Rezac, Nicholas J. Kocmich, Tolulope Oginni, BS, Grace Mfon Olanipekun, Fatimah Hassan-Hanga, MD, Binta W. Jibir, MBBS MPH, Safiya Gambo, MBBS, Priyaleela Thota, MD, Stephen K. Obaro, MD PhD, Umut A. Gurkan, PhD

Blood (2019) 134 (Supplement_1): 2173.

https://doi.org/10.1182/blood-2019-131344

Published: 2019

Journal Articles

Availability of ATRA, Blood BANK Support, Treatment Protocols and Hematologists/Oncologists for Management of APL in Two States (MICHIGAN AND LOUSIANA)

Sheldon Bolds, Shruthi M.K Hassan, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Arpita Gandhi, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5620.

https://doi.org/10.1182/blood.V130.Suppl_1.5620.5620

Published: 2017

Journal Articles

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Maria Luci, MD, Maria Aquila Santoro, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2016) 128 (22): 1269.

https://doi.org/10.1182/blood.V128.22.1269.1269

Published: 2016

Journal Articles

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

Sarah Wheeler, PharmD, Harika Puttagunta, MD, Minal Surati, PharmD, Elyse Panjic, PharmD, Arpita Shah, PharmD, Martha Arellano, MD, Anand Jillella, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 4924.

https://doi.org/10.1182/blood.V126.23.4924.4924

Published: 2015

Journal Articles

California Umbilical Cord Blood Collection Program: Addressing The Diversity Of The National Registry Through Creative Partnerships With Cord Blood Banks and Provision Of High-Quality Cord Blood Units For Research

Jon Walker, CLS, Geralyn Annett, CLS, Karen O'Donnell, B.S., Christine C. Posey, B.S., Delia Roberts, CHES, Kevin Yanamura, CLS, Jan A. Nolta, PhD, Suzanne Pontow, Ph.D.

Blood (2013) 122 (21): 5441.

https://doi.org/10.1182/blood.V122.21.5441.5441

Published: 2013

Journal Articles

The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Beverley J Hunt, MD

Blood (2010) 116 (21): 3179.

https://doi.org/10.1182/blood.V116.21.3179.3179

Published: 2010

Journal Articles

Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Kiran Parmar, MSc, Beverley J Hunt, MD

Blood (2010) 116 (21): 4216.

https://doi.org/10.1182/blood.V116.21.4216.4216

Published: 2010

Journal Articles

Clinical Outcomes with the LMWH, Tinzaparin (Innohep®) in Pregnancy. An International Retrospective Audit..

Marc Rodger, MD, MSc, Cathy Nelson-Piercy, Raymond Powrie, Jeanne-Yvonne Borg, Ian Greer

Blood (2009) 114 (22): 487.

https://doi.org/10.1182/blood.V114.22.487.487

Published: 2009

Journal Articles

The True Cost of Red Blood Cell Transfusion in Surgical Patients

Aryeh Shander, MD, Axel Hofmann, ME, Sherri Ozawa, RN, Mazyar Javidroozi, MD

Blood (2008) 112 (11): 3045.

https://doi.org/10.1182/blood.V112.11.3045.3045

Published: 2008

Journal Articles

Feasibility of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy for Non-Hodgkin’s Lymphoma in a Patient with Chronic Renal Failure.

Stewart M. Spies, MD, Leo I. Gordon, MD, A. Michael Zimmer, PHD, Peter Cutrera, CNMT

Blood (2004) 104 (11): 4642.

https://doi.org/10.1182/blood.V104.11.4642.4642

Published: 2004

NARROW

Advancing Healthcare Outcomes for Sickle Cell Disease in Nigeria Using Mobile Health Tools

Availability of ATRA, Blood BANK Support, Treatment Protocols and Hematologists/Oncologists for Management of APL in Two States (MICHIGAN AND LOUSIANA)

Rituximab Subcutaneous Formulation (SC-R) Is Safe, Effective and Cost-Saving in Patients Suffering from Autoimmune Hemolytic Anemia (AIHA)

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

California Umbilical Cord Blood Collection Program: Addressing The Diversity Of The National Registry Through Creative Partnerships With Cord Blood Banks and Provision Of High-Quality Cord Blood Units For Research

The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Clinical Outcomes with the LMWH, Tinzaparin (Innohep®) in Pregnancy. An International Retrospective Audit..

The True Cost of Red Blood Cell Transfusion in Surgical Patients

Feasibility of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy for Non-Hodgkin’s Lymphoma in a Patient with Chronic Renal Failure.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only